Delivery Order SPE2DB22D6029-SPE2DB25FLTUU
Award Date
1/24/25
Potential Completion Date
1/27/25
Potential Value
$5.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,232.50 firm fixed-price delivery order is for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product, with a period of performance running through January 14, 2025. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This federal contract award is a delivery order with a firm fixed price valued at $10,987.03. It was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MAVYRET 100-40 MG TABLET 84S, a medical product, with a period of performance through May 12, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
This federal contract award, with ID SPE2DX15D3021|SPE2DX23F1KW9, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,746.55 firm fixed-price delivery order is for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product, with a performance period ending on May 2, 2023. This award is not designated as a set-aside contract. The prime contractor,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a Delivery Order (DO) under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC), valued at up to $999,999,999. The award is for the supply of MAVYRET 100-40 MG TABLET 84S, a pharmaceutical product, with a ceiling value of $64,020.92 and a completion date of September 10, 2024. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal...
This federal contract award, valued at $6,943.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of a pharmaceutical product, specifically the medication MAVYRET 100-40 MG TABLET 84S, to support the Department of Defense (DoD) and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) on September 12, 2022. The $80,535.22 firm fixed-price delivery order provides the DLA with Harvoni 90-400 mg tablets. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that runs through November 2026. This IDC serves...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $143,502.37 and provides HARVONI 90-400 MG 28S, a specialty pharmaceutical product, to support military healthcare programs. The contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999...
This federal contract award SPE2DX15D6028|G559, valued at $153,070.42, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Harvoni 90-400 mg tablets, a pharmaceutical product used to treat hepatitis C. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,190.29 firm fixed-price delivery order is for the supply of HEPSERA 10 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of August 2, 2021 and was awarded on July 30, 2021. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,746.52, is a Firm Fixed Price Delivery Order for the supply of SOFOSBUVIR-VELPATASVIR 400-100 28S, a medication used for the treatment of hepatitis C. The contract has an ultimate completion date of January 14, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...